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A visual and fluorogenic detection method for a nerve agent
simulant was developed based on a Lossen rearrangement of
rhodamine–hydroxamate, in the presence of diethyl chlorophos-
phate, under alkaline conditions.
Nerve agents, including Tabun, Sarin, and Soman, are
chemically active organophosphates that can inactivate acetyl-
cholinesterase via irreversible modification of the catalytically
essential serine residue in the enzyme active site.1 Inhibition of
acetylcholinesterase leads to accumulation of acetylcholine,
which leads to neuromuscular paralysis and eventually
death.2,3 The utility of nerve agents stems from their extra-
ordinary toxicity; a lethal dose can be as little as 0.70 mg for an
average 70 kg man. Nerve agents are an increasing homeland
security concern due to the horrifying effects that could be
realized from a terrorist attack. Sarin is probably the most
feared chemical agent because it has actually been used by
terrorists. In 1995, the Aum Shinrikyo group released Sarin
gas in the Tokyo subway, leading to thousands of wounded
and 12 deaths.4 As such, methods allowing facile and sensitive
detection of nerve agents will be desirable to both government
officials and the general public.
Systems that have been utilized to detect nerve agents
include liquid chromatography/mass spectrometry, enzyme
based biosensors etc.5–7 These conventional methods usually
show limitations, such as lack of portability or storage/stability
issues that limits their success in some conditions. The challenge
to the scientific community is to invent methods and devices
that are compact, portable and capable of real time detection.
Chemosensors are advantageous in the aforementioned aspects
as they require widely used instruments and offer the possibility
to detect nerve agents with the naked eye. Chemosensors that
exhibit either distinguished fluorescence emission properties or
change color in the presence of nerve agents have been
extensively investigated.8–21 In some chromogenic/fluoregenic
assays, carefully designed substrates could react with nerve
agent mimics to directly afford either detectable species,19,21 or
to form intermediates, which could further undergo intra-
molecular transformations in situ to generate chromophores
or fluorophores for signal detection.10,19–21 Alternatively, in
other assay systems,11,12,14,17,20 selected fluorophores were
covalently attached or complexed with fluorescence quenchers.
Upon reaction with nerve agents, the quenching effects were
diminished or inhibited, allowing the recovery of the masked
fluorescence.
Selected functional groups, mainly amino,11 hydroxyl,10,12,17,20
or oxime moieties,13,16,19,21,22 have been employed as the initial
anchoring points for nerve agent simulants in many of the
reported chemical reagent based assays.
Herein, we report a new nerve agent sensor, which contains
a hydroxamate group that acts as a nucleophile and reacts with
organophosphate. Rhodamine B was treated with hydroxyl-
amine to give nonfluorescent rhodamine–hydroxymate under
basic conditions. The hallmark of rhodamine–hydroxamate
is the formation of the intramolecular 5-membered spiro-
lactam (Scheme 1). Upon addition of diethyl chlorophosphate
which was used as the nerve agent simulant, the rhodamine–
hydroxymate solution gradually turned red in color (Fig. 1).
Historically, nonfluorescent and colorless rhodamine deriva-
tives with spirolactam have been extensively utilized to detect
metal ions by virtue of reversible ring-opening of the spiro-
lactam, which gives rise to a highly fluorescent and colored
rhodamine fluorophore.23–27 Particularly, the hydroxamic acid
derivatives of rhodamine B and rhodamine 6G have been
evaluated for fluorescent imaging of cellular hypochlorous
acid by oxidation promoted irreversible ring opening of the
spirolactam.28 Herein, we report the irreversible ring opening
of rhodamine spirolactam via a Lossen rearrangement in the
presence of reactive organophosphate.
To optimize the assay, the reaction rates of diethyl chloro-
phosphate with rhodamine–hydroxamate under a variety of
conditions were monitored with UV-vis absorbance at 590 nm.
Time course studies of the reaction rates showed that
dimethylformaldehyde (DMF) was the preferred assay medium
relative to other less polar solvents, and the assay was
catalyzed efficiently in DMF containing a variety of bases
such as triethylamine (TEA), piperidine etc. Under the examined
conditions, color development was found to be proportional
to the incubation time, indicating that the opening of the
spirolactam of compound 1 was the rate limiting step in the
assay conditions. The assay was as efficient in the presence of
up to 5% (v/v) water included in the reaction solution as that
in anhydrous DMF (ESI, SFig. 4w). The tolerance of water in
Scheme 1 Fluorogenic and chromogenic reaction of rhodamine–
hydroxamate with diethyl chlorophosphate.
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the assay system is probably due to quicker formation of
compound 1 relative to the hydrolysis of diethyl chloro-
phosphate. The effectiveness of the assay in the presence of
water suggests its robustness in monitoring nerve agents under
selected practical conditions.
To test the sensitivity of the rhodamine–hydroxamate based
assay towards nerve agents, diethyl chlorophosphate was added
to the solution of rhodamine–hydroxamate (1 mg mL1)
in DMF containing TEA (3%, v/v) to prepare a serial of
reaction solutions with various concentrations of the
analyst. The reactions were incubated at room temperature
for 20 min and then the fluorescence emission spectra recorded
(Ex: 560 nm). As can been seen from Fig. 2, the maximum
fluorescence emission intensity at 590 nm increased as a function
of diethyl chlorophosphate concentration. An amount of diethyl
chlorophosphate as low as 25 ppm can be clearly identified
under the assay condition (510 RFU relative to the background
of 90 RFU). Since the color of the reaction solution was
developed in a time dependant manner, the assay limits could
be further extended by elongation of the incubation time.
The reaction of rhodamine–hydroxamate with diethyl chloro-
phosphate was monitored with thin layer chromatography. It
was shown that rhodamine–hydroxamate was consumed in
minutes upon addition of slightly excess diethyl chloro-
phosphate. A colorless intermediate adduct was quickly formed,
while several colored species appeared and gradually accumu-
lated. To access the identity of the intermediate adduct, which
is presumably compound 1 (Scheme 1), the reaction solution
was analyzed by high resolution mass spectrometry (HRMS),
Fig. 3. A major peak located at 594.2739 was identified,
which is consistent with the theoretical molecular weight of
compound 1 (C32H41N3O6P+; MW: 594.2733), confirming
formation of compound 1 in the assay system. The UV-vis
absorption spectrum of the reaction solution revealed a
new strong absorption band at 560 nm, which intensified as
a function of time (ESI, SFig. 3 and 4w). The fluorescence
excitation and emission spectra of the resulting solution
were shown to be almost identical to that of rhodamine B
(ESI, SFig. 1 and 2w), indicating the formation of a rhodamine
fluorophore from the ring opening of spirolactam in com-
pound 1 under the assay conditions (Scheme 2).
Known as the Lossen rearrangement, hydroxamic acids are
able to be converted to O-acyl, sulfonyl, or phosphoryl inter-
mediates, which will then self-rearrange into the corresponding
isocyanates.29–33 We reasoned that ring opening of the spiro-
lactam in compound 1 might be performed via a Lossen
rearrangement. Based on this hypothesis, compound 2 with
an isocyanate functionality will be formed from compound 1
(Scheme 2). As the isocyanate group is chemically very
reactive, it is prone to further reactions with a variety of
nucleophiles. In the presence of water, compound 2 will be
hydrolyzed to afford compound 3, which will decompose to
liberate a molecule of carbon dioxide to yield compound 4.
Formation of compound 2, 3 and 4, which share a common
structural motif of the fluorescent and colored rhodamine
fluorophore, would contribute to the formation of the observed
colored species in the assay. To probe the molecular identities
of the colored species generated in the rhodamine–hydroxamate
based assay solution, the reaction solution was subjected to
high resolution mass spectrometry analysis. As shown in
Scheme 2 and Fig. 4, peaks representative of compound 2, 3
and 4 were all shown to be present in the reaction solution,
supporting the hypothesis that the color development was
achieved through a Lossen rearrangement of compound 1.
Besides O-phosphoryl derivatives of hydroxamate, the O-acyl,
and sulfonyl intermediates of hydroxamate are also poised to
undergo Lossen rearrangement.29–33 In a separate experiment,
Fig. 1 Comparison of rhodamine–hydroxamate solution (1 mg mL1)
in DMF containing TEA (3%, v/v) before (left) and after (right)
addition of diethyl chlorophosphate (250 ppm).
Fig. 2 Fluorescence emission spectra of diethyl chlorophosphate
detected with rhodamine–hydroxamate. Analyst concentration utilized:
500, 170, 100, 50, 25, and 0 ppm (From top to the bottom).
Fig. 3 HRMS confirmation of compound 1 in rhodamine–hydroxamate
based assay solution of diethyl chlorophosphate.
Scheme 2 Proposed intermediates generated via a Lossen rearrange-
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color developments of rhodamine–hydroxamate in the presence
of 4-toluenesulfonyl chloride or benzyl chloroformate were also
observed, supporting the role of the Lossen rearrangement in
the assay. The highly fluorescent and deep colored properties of
the intermediates resulting from the Lossen rearrangement
allow instrumental quantitation as well as ‘naked-eye’ detection
of a broad range of reactive organophosphates.
It is preferential to detect ppb level of nerve agents in the gas
phase for practical applications. Here we show that rhodamine–
hydroxamate is able to assay a single aliquot of diethyl
chlorophosphate in DMF solution at ppm range. In practical
applications, detection of a lower level of nerve agent might be
achieved by bubbling a larger volume of contaminated air into
the assay solution. Currently the conjugation of rhodamine–
hydroxmate with functional solid materials are being investi-
gated for detection of gas phase nerve agents with enhanced
sensitivity. Organophosphate promoted Lossen rearrangement
of rhodamine–hydroxmate offers a fluorogenic and colorimetric
chemical transformation that might be useful for design of a
nerve agent assay kit.
In summary, a visual and highly fluorescent detection method
for a nerve agent simulant was developed based on a Lossen
rearrangement of rhodamine–hydroxamate in the presence of
reactive organophosphate. The assay was sensitive enough to
detect 25 ppm of nerve agent mimics in 20 min, and was robust
enough to be assayed under humid conditions, suggesting its
potential utility for on-spot detection of nerve agents with the
aid of instruments or possibly with the ‘naked eye’.
This work was financially supported by Molecular Cloning
Laboratories (South San Francisco, CA) and the National
Natural Science Foundation of China (No. 20802060).
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